The Advisory Committee on Immunization Practices (ACIP) yesterday agreed to a mix-and-match approach for COVID-19 vaccines, and approved the inclusion of Medigen Vaccine Biologics Corp’s (高端疫苗) COVID-19 vaccine in the national vaccination program.
Minister of Health and Welfare Chen Shih-chung (陳時中), who heads the Central Epidemic Command Center (CECC), said it was agreed at an ACIP meeting yesterday morning that a mix-and-match approach was acceptable for people receiving two doses of COVID-19 vaccines.
Most people in the first three COVID-19 vaccination priority groups have received a first dose of the AstraZeneca vaccine, Chen said.
Photo: Huang Shu-li, Taipei Times
Specialists in the committee said people in those groups should be allowed to receive a mRNA vaccine for their second dose, at least eight weeks after their first dose, he said.
However, to keep the vaccination policy consistent, the center would arrange for the second dose of the mix-and-match regimen to be administered 10 to 12 weeks after the first dose, he said.
Asked when the mix-and-match vaccination strategy would be implemented, Chen said that a date has not yet been set, as the ACIP’s decision was only reached at noon yesterday.
The CECC must still discuss plans for the strategy’s implementation, as well as modify the online vaccination booking system to allow for the mixing of doses, Chen said.
The ACIP also approved the domestic Medigen vaccine for inclusion in the national vaccination program, he said.
Regarding rollout of the Medigen vaccine, Chen said the CECC would need to meet with the vaccine maker to confirm its supply plan and schedule.
Medigen obtained Emergency Use Authorization for its vaccine from the Food and Drug Administration on Monday last week, the first local vaccine maker to do so.
The administration based its decision on data Medigen obtained in a phase 2 clinical trial involving about 4,000 participants earlier this year, which was analyzed using immunobridging and compared to a control group of 200 AstraZeneca vaccine recipients in Taoyuan.
Medigen has said it has permission to conduct a phase 3 clinical trial among 1,000 people in Paraguay.
Additional reporting by CNA
EUROPEAN TARGETS: The planned Munich center would support TSMC’s European customers to design high-performance, energy-efficient chips, an executive said Taiwan Semiconductor Manufacturing Co (TSMC, 台積電), the world’s largest contract chipmaker, yesterday said that it plans to launch a new research-and-development (R&D) center in Munich, Germany, next quarter to assist customers with chip design. TSMC Europe president Paul de Bot made the announcement during a technology symposium in Amsterdam on Tuesday, the chipmaker said. The new Munich center would be the firm’s first chip designing center in Europe, it said. The chipmaker has set up a major R&D center at its base of operations in Hsinchu and plans to create a new one in the US to provide services for major US customers,
The Ministry of Transportation and Communications yesterday said that it would redesign the written portion of the driver’s license exam to make it more rigorous. “We hope that the exam can assess drivers’ understanding of traffic rules, particularly those who take the driver’s license test for the first time. In the past, drivers only needed to cram a book of test questions to pass the written exam,” Minister of Transportation and Communications Chen Shih-kai (陳世凱) told a news conference at the Taoyuan Motor Vehicle Office. “In the future, they would not be able to pass the test unless they study traffic regulations
‘A SURVIVAL QUESTION’: US officials have been urging the opposition KMT and TPP not to block defense spending, especially the special defense budget, an official said The US plans to ramp up weapons sales to Taiwan to a level exceeding US President Donald Trump’s first term as part of an effort to deter China as it intensifies military pressure on the nation, two US officials said on condition of anonymity. If US arms sales do accelerate, it could ease worries about the extent of Trump’s commitment to Taiwan. It would also add new friction to the tense US-China relationship. The officials said they expect US approvals for weapons sales to Taiwan over the next four years to surpass those in Trump’s first term, with one of them saying
‘COMING MENACINGLY’: The CDC advised wearing a mask when visiting hospitals or long-term care centers, on public transportation and in crowded indoor venues Hospital visits for COVID-19 last week increased by 113 percent to 41,402, the Centers for Disease Control (CDC) said yesterday, as it encouraged people to wear a mask in three public settings to prevent infection. CDC Epidemic Intelligence Center Deputy Director Lee Chia-lin (李佳琳) said weekly hospital visits for COVID-19 have been increasing for seven consecutive weeks, and 102 severe COVID-19 cases and 19 deaths were confirmed last week, both the highest weekly numbers this year. CDC physician Lee Tsung-han (李宗翰) said the youngest person hospitalized due to the disease this year was reported last week, a one-month-old baby, who does not
RSS